SCHEMBL31630529

SCHEMBL31630529

[2H]C1([2H])C([2H])([2H])C(CO)(Nc2nc(Cl)nc3c2[S@+]([O-])CC3)C1([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491332 0.88 — —
SCHEMBL30639341 0.85 LATS1 (0.32) —
SCHEMBL29576569 0.85 LATS1 (0.32) —
SCHEMBL31571836 0.85 LATS1 (0.32) —
SCHEMBL30639342 0.85 LATS1 (0.32) —
SCHEMBL30639365 0.83 — —
SCHEMBL31622416 0.81 — —
SCHEMBL31002980 0.81 — —
SCHEMBL30678865 0.80 LATS1 (0.32) —
SCHEMBL30678840 0.80 LATS1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025124557-A1 DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF 武汉人福创新药物研发中心有限公司 2025-06-19 — — WO disclosed
Send feedback